Compare CRCT & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | CDNA |
|---|---|---|
| Founded | 1969 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 857.6M | 1.0B |
| IPO Year | 2021 | 2007 |
| Metric | CRCT | CDNA |
|---|---|---|
| Price | $4.11 | $17.09 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $3.50 | ★ $27.33 |
| AVG Volume (30 Days) | ★ 621.5K | 534.7K |
| Earning Date | 03-03-2026 | 04-29-2026 |
| Dividend Yield | ★ 23.28% | N/A |
| EPS Growth | ★ 20.69 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $708,780,000.00 | $48,324,000.00 |
| Revenue This Year | $0.08 | $15.37 |
| Revenue Next Year | $0.98 | $11.23 |
| P/E Ratio | $11.73 | ★ N/A |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $3.92 | $10.96 |
| 52 Week High | $7.33 | $21.49 |
| Indicator | CRCT | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 39.47 |
| Support Level | $3.92 | $16.62 |
| Resistance Level | $4.83 | $17.09 |
| Average True Range (ATR) | 0.15 | 0.70 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 30.53 | 24.84 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.